Projects per year
Fingerprint
Dive into the research topics where Brad Harris Rovin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)
Buyon, J. (PI), Rovin, B. H. (CoPI), Petri, M. M. A. (CoPI) & Werth, V. (CoPI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
03/21/22 → 12/31/25
Project: Research
-
Targeting Aberrant Expression of Cytokines/Chemokines for an Inflammatory Nephritis Cure
Lin, P.-H. (PI) & Rovin, B. H. (CoPI)
National Institute of Allergy and Infectious Diseases
06/22/22 → 05/31/24
Project: Research
-
Muscle-Kidney Crosstalk in Age-related Kidney Disease
Lin, P.-H. (PI), Rovin, B. H. (CoPI) & Tan, T. (CoPI)
09/1/20 → 04/30/25
Project: Research
-
Nephron Sub-segmental Omics and Quantitative 3D Imaging of Human Kidney.
Dagher, P. C. (PI), Ashkar, T. M. (CoPI) & Rovin, B. H. (CoPI)
National Institute of Diabetes and Digestive and Kidney Diseases
07/1/18 → 06/30/21
Project: Research
-
Predictive Biomarkers for disease activity and organ damage in patients with lupus
Tsao, B. P. (PI), Oates, J. (CoPI) & Rovin, B. H. (CoPI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
05/27/18 → 04/30/24
Project: Research
-
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
APPLAUSE-IgAN Investigators, Feb 6 2025, In: New England Journal of Medicine. 392, 6, p. 531-543 13 p.Research output: Contribution to journal › Article › peer-review
31 Scopus citations -
Comment on: Renal arteriosclerosis in kidney biopsies associated with higher 10-year atherosclerotic cardiovascular disease in lupus nephritis: Reply
Garg, S., Rovin, B., Raval, A. N. & Bartels, C. M., May 1 2025, In: Rheumatology. 64, 5, p. 3200-3201 2 p.Research output: Contribution to journal › Letter › peer-review
-
Corrigendum to “KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis.” Kidney International 2024;105(3S):S71–S116 (Kidney International (2024) 105(3S) (S71–S116), (S0085253823007445), (10.1016/j.kint.2023.10.008))
Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group, Feb 2025, In: Kidney International. 107, 2, p. 367 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Designing clinical trials for the treatment of membranous nephropathy in the anti-PLA2R era: results of a Nephcure membranous nephropathy workshop
Prunotto, M., Nachman, P. H., Gillespie, B. S., Beck, L. H., Thompson, A. M., Hu, A. H., Stafford, E. A., Tarnoff, J. M. & Rovin, B. H., May 2025, In: Kidney International. 107, 5, p. 809-815 7 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
REGENCY Trial Investigators, Apr 17 2025, In: New England Journal of Medicine. 392, 15, p. 1471-1483 13 p.Research output: Contribution to journal › Article › peer-review
19 Scopus citations